Dr Bree Foley is a cellular immunologist with the goal to understand the immune response to paediatric cancers and to identify new ways to harness these responses. She completed her PhD at the University of Western Australia investigating the immunogenetics of natural killer cell anti-leukaemic function. Dr Foley then undertook post-doctoral training at one of the top translational NK cell laboratories at the University of Minnesota. Here, she published several influential papers (in leading journals such as Blood and Immunity) in understanding NK cell functional potential and developing new therapeutics to treat cancer. Based on results directly obtained during her post-doctoral studies, patients with relapsed and refractory leukaemia are now enrolled in promising clinical trials that have the potential to significantly increase their survival. Since returning to Perth, Dr Foley has established a research program investigating how to enhance natural killer (NK) cells functional capacity using cutting edge molecular and immunological tools. Through her research, Dr Foley hopes to identify new and novel therapies for the treatment of cancer. In addition to her research, Dr Foley dedicates her time to supporting, training and mentoring both students and EMCRs and the wider research community through her time on the Australian and New Zealand Society for Immunology Council and the Australian Society for Medical Research Board. Dr Foley is also passionate about education with experience in both undergraduate and postgraduate teaching in immunology and genetics. She has a keen interest in exploring different pedagogies for teaching science and supporting the learning needs of her students.